XILIO THERAPEUTICS INC. - COMMON STOCK

Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer

05 9月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

05 9月 2023 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results

14 8月 2023 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Promotion of Chris Frankenfield to Chief Operating Officer

03 8月 2023 16:05:01 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Preliminary Clinical Data from Phase 1 Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Patients with Advanced Solid Tumors

25 5月 2023 17:01:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results

09 5月 2023 07:30:01 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

03 4月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates for the Fourth Quarter and Full Year 2022 Financial Results

02 3月 2023 16:05:01 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Upcoming Investor Conferences

27 2月 2023 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summit

16 2月 2023 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

02 2月 2023 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12

23 11月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results

09 11月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’ Summit

04 11月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference

22 9月 2022 16:05:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Appoints Tomas J. Heyman to Board of Directors

15 9月 2022 16:05:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference

06 9月 2022 16:05:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Encouraging Preliminary Phase 1 Dose-Escalation Data for XTX101, a Tumor-Selective Anti-CTLA-4, and Reports Pipeline and Business Updates and Second Quarter 2022 Financial Results

09 8月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President

16 6月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference

18 5月 2022 07:30:00 条件 Nasdaq GlobeNewswire